Viewing StudyNCT00310232



Ignite Creation Date: 2024-05-05 @ 4:46 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00310232
Status: TERMINATED
Last Update Posted: 2024-04-02
First Post: 2006-03-31

Brief Title: Epoetin Alfa in Advanced Non-Small Cell Lung Cancer EPO-CAN-20
Sponsor: Ontario Clinical Oncology Group OCOG
Organization: Ontario Clinical Oncology Group OCOG

Organization Data

Organization: Ontario Clinical Oncology Group OCOG
Class: OTHER
Study ID: CTA-Control-076080
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Ontario Clinical Oncology Group OCOG
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Ortho Biotech Inc INDUSTRY